Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Charles F Jr Wagner is EVP, CO & FO at Vertex Pharmaceuticals. OQRO lists 19 transactions filed with the SEC under this name, the latest on Nov 16, 2026, each linked to the official Form 4.
EVP, CO & FO
Disclosures on record
19
Companies involved
2
As of the latest filing on , Charles F Jr Wagner reported holding 31,764 shares of Vertex Pharmaceuticals (VRTX), worth about $17.1M at the last close of $538 (Nov 16, 2026). In the last 12 months, Charles F Jr Wagner sold $19.2M in 4 sales.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Vertex Pharmaceuticals VRTX | 31,764 | 32K direct | $538 | $17.1M | Nov 12, 2026 |
Is this Charles F Jr Wagner’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Vertex PharmaceuticalsVRTX
15 disclosures · Nov 2024 – Nov 2026 · 6 sold
Nov 12, 2026Sold~$8.37Mdisclosed Nov 16
DetailsOfficial recordFeb 24, 20261,744disclosed Feb 26
DetailsOfficial recordFeb 17, 20267,365disclosed Feb 19
DetailsOfficial recordFeb 17, 20262,294disclosed Feb 19
DetailsOfficial recordFeb 13, 20264,565disclosed Feb 18
DetailsOfficial recordFeb 10, 20263,045disclosed Feb 12
DetailsOfficial recordJan 22, 20269,440disclosed Jan 26
DetailsOfficial recordJan 22, 20264,160disclosed Jan 26
DetailsOfficial recordJan 6, 2026Sold~$4.39Mdisclosed Jan 8
DetailsOfficial recordJan 6, 20269,532disclosed Jan 8
DetailsOfficial recordJan 6, 20269,532disclosed Jan 8
DetailsOfficial recordDec 3, 2025Sold~$3.23Mdisclosed Dec 5
DetailsOfficial recordDec 3, 2025Sold~$3.16Mdisclosed Dec 5
DetailsOfficial recordMar 10, 2025Sold~$1.65Mdisclosed Mar 12
DetailsOfficial recordNov 11, 2024Sold~$1.55Mdisclosed Nov 13
DetailsOfficial recordTJX CompaniesTJX
4 disclosures · Jun 2026
Jun 9, 2026636.87disclosed Jun 11
DetailsOfficial recordJun 9, 202626.5disclosed Jun 11
DetailsOfficial recordJun 9, 2026636.87disclosed Jun 11
DetailsOfficial recordJun 9, 202626.5disclosed Jun 11
DetailsOfficial recordOn the latest SEC Form 4, dated Nov 12, 2026, Charles F Jr Wagner reported holding 31,764 shares of Vertex Pharmaceuticals (VRTX). At the last close of $538 on Nov 16, 2026, that is about $17.1M. This is the stake disclosed in filings, not a net worth.
In SEC filings of the last 12 months, Charles F Jr Wagner reported 4 open-market sales worth $19.2M, and no open-market purchase. Shares withheld for taxes, gifts and option exercises are not counted in these totals.
Charles F Jr Wagner has no open-market purchase on record since 2015 across 2 companies. Sales in each of the last 5 years.
In SEC filings since 2015: no open-market purchase is on record; the latest open-market sale is from 2026.
2 companies: Vertex Pharmaceuticals (VRTX, 2020–2026), Bruker (BRKR, 2015).
Charles F Jr Wagner has no open-market purchase on record since 2015 across 2 companies. Sales in each of the last 5 years.
Charles F Jr Wagner reported 0 open-market purchases and 50 sales since 2015; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2026 | — | $12.8M2×2 trades |
| 2025 | — | $8.03M3×3 trades |
| 2024 | — | $5.74M4×4 trades |
| 2023 | — | $3.57M22×22 trades |
| 2022 | — | $2.3M15×15 trades |
| 2020 | — | $205K3×3 trades |
| 2015 | — | $360K1×1 trade |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Charles F Jr Wagner reported 0 open-market purchases and 49 sales here, 2020 to 2026.
Charles F Jr Wagner reported 0 open-market purchases and 1 sale here, 2015.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.